Skip to main content
Top
Published in: Pediatric Cardiology 2/2012

01-02-2012 | Original Article

Plasmin Generation and Fibrinolysis in Pediatric Patients Undergoing Cardiopulmonary Bypass Surgery

Authors: Vera Ignjatovic, Aparajith Chandramouli, Jenny Than, Robyn Summerhayes, Fiona Newall, Steve Horton, Andrew Cochrane, Paul Monagle

Published in: Pediatric Cardiology | Issue 2/2012

Login to get access

Abstract

This prospective, single-centre cohort study aimed to evaluate plasmin generation and fibrinolysis during and after cardiopulmonary bypass (CPB) surgery in a cohort of children up to 6 years of age. Blood samples were drawn at eight time points: after induction of anesthesia, before unfractionated heparin (UFH), after UFH, after initiation of bypass, before protamine, after protamine, after chest closure, and 6 h after chest closure. The study identified an increase in fibrinolysis during CPB and particularly up to 6 h afterward in children. This could be the mechanism for the significant bleeding events observed in this young population after CPB. This study establishes the foundation for future studies in this area, particularly those focusing on clinical outcomes after CPB surgery.
Literature
1.
go back to reference Andrew M, Paes B, Johnston M (1990) Development of the hemostatic system in the neonate and young infant. Blood 12:95–104 Andrew M, Paes B, Johnston M (1990) Development of the hemostatic system in the neonate and young infant. Blood 12:95–104
2.
go back to reference Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM et al (1987) Development of the human coagulation system in the full-term infant. Blood 70:165–172PubMed Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM et al (1987) Development of the human coagulation system in the full-term infant. Blood 70:165–172PubMed
3.
go back to reference Bouma BN, Mosnier LO (2006) Thrombin activatable fibrinolysis inhibitor (TAFI): How does thrombin regulate fibrinolysis? Ann Med 38:378–388PubMedCrossRef Bouma BN, Mosnier LO (2006) Thrombin activatable fibrinolysis inhibitor (TAFI): How does thrombin regulate fibrinolysis? Ann Med 38:378–388PubMedCrossRef
4.
go back to reference Chan AK, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, Adams M, Brooker LA, Adams H, Mitchell L, Andrew M (1997) Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 77:270–277PubMed Chan AK, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, Adams M, Brooker LA, Adams H, Mitchell L, Andrew M (1997) Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 77:270–277PubMed
5.
go back to reference Chandler WL (2005) Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 19:459–467PubMedCrossRef Chandler WL (2005) Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 19:459–467PubMedCrossRef
6.
go back to reference Corrigan JJ Jr, Sleeth JJ, Jeter M, Lox CD (1989) Newborn’s fibrinolytic mechanism: components and plasmin generation. Am J Hematol 32:273–278PubMedCrossRef Corrigan JJ Jr, Sleeth JJ, Jeter M, Lox CD (1989) Newborn’s fibrinolytic mechanism: components and plasmin generation. Am J Hematol 32:273–278PubMedCrossRef
7.
go back to reference Davies LK (1999) Cardiopulmonary bypass in infants and children: How is it different? J Cardiothorac Vasc Anesth 13:330–345PubMedCrossRef Davies LK (1999) Cardiopulmonary bypass in infants and children: How is it different? J Cardiothorac Vasc Anesth 13:330–345PubMedCrossRef
8.
go back to reference Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA (1995) Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery: a double-blind, placebo-controlled study. Anesthesiology 83:679–689PubMedCrossRef Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA (1995) Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery: a double-blind, placebo-controlled study. Anesthesiology 83:679–689PubMedCrossRef
9.
go back to reference Eisses MJ, Seidel K, Aldea GS, Chandler WL (2004) Reducing hemostatic activation during cardiopulmonary bypass: a combined approach. Anesth Analg 98:1208–1216PubMedCrossRef Eisses MJ, Seidel K, Aldea GS, Chandler WL (2004) Reducing hemostatic activation during cardiopulmonary bypass: a combined approach. Anesth Analg 98:1208–1216PubMedCrossRef
10.
go back to reference Guay J, Rivard GE (1996) Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 62:1955–1960PubMedCrossRef Guay J, Rivard GE (1996) Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 62:1955–1960PubMedCrossRef
11.
go back to reference Hunt B, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M (1998) Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 65:712–718PubMedCrossRef Hunt B, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M (1998) Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 65:712–718PubMedCrossRef
12.
go back to reference Ignjatovic V, Than J, Summerhayes R, Newall F, Horton S, Cochrane A, Monagle P (2011) Hemostatic response in paediatric patients undergoing cardiopulmonary bypass surgery. Ped Cardiol 32(5):621–627CrossRef Ignjatovic V, Than J, Summerhayes R, Newall F, Horton S, Cochrane A, Monagle P (2011) Hemostatic response in paediatric patients undergoing cardiopulmonary bypass surgery. Ped Cardiol 32(5):621–627CrossRef
13.
go back to reference Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Healey NA, MacGregor H, Doursounian M, Zolkewitz MA (1995) Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 60:1008–1014PubMedCrossRef Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Healey NA, MacGregor H, Doursounian M, Zolkewitz MA (1995) Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 60:1008–1014PubMedCrossRef
14.
go back to reference Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, Buller HR (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947PubMedCrossRef Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, Buller HR (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947PubMedCrossRef
15.
go back to reference Mossinger H, Dietrich W (1998) Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg 65(6 Suppl):S45–S50PubMedCrossRef Mossinger H, Dietrich W (1998) Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg 65(6 Suppl):S45–S50PubMedCrossRef
16.
go back to reference Mossinger H, Dietrich W, Braun SL, Jochum M, Meisner H, Richter JA (2003) High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 75:430–437PubMedCrossRef Mossinger H, Dietrich W, Braun SL, Jochum M, Meisner H, Richter JA (2003) High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 75:430–437PubMedCrossRef
17.
go back to reference Parmar N, Mitchell LG, Berry LR, Andrew M, Chan AK (2006) The influence of age on in vitro plasmin generation in the presence of fibrin monomer. Acta Haematol 115:141–151PubMedCrossRef Parmar N, Mitchell LG, Berry LR, Andrew M, Chan AK (2006) The influence of age on in vitro plasmin generation in the presence of fibrin monomer. Acta Haematol 115:141–151PubMedCrossRef
18.
go back to reference Parmar N, Albisetti M, Berry LR, Chan AK (2006) The fibrinolytic system in newborns and children. Clin Lab 52:115–124PubMed Parmar N, Albisetti M, Berry LR, Chan AK (2006) The fibrinolytic system in newborns and children. Clin Lab 52:115–124PubMed
19.
go back to reference Parmar N, Mitchell LG, Berry LR, Andrew M, Chan AK (2006) The influence of age on in vitro plasmin generation in the presence of fibrin monomer. Acta Haematol 115:141–151PubMedCrossRef Parmar N, Mitchell LG, Berry LR, Andrew M, Chan AK (2006) The influence of age on in vitro plasmin generation in the presence of fibrin monomer. Acta Haematol 115:141–151PubMedCrossRef
20.
go back to reference Ray MJ, Marsh NA, Hawson GA (1994) Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinolysis 5:679–685PubMedCrossRef Ray MJ, Marsh NA, Hawson GA (1994) Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinolysis 5:679–685PubMedCrossRef
21.
go back to reference Summerhayes R, Ignjatovic V, Hall M, Monagle P (2007) Age-related reference ranges for TAFI and fibrin monomers in healthy children. J Throm Haemost 5(Suppl 2):P-S-397 Summerhayes R, Ignjatovic V, Hall M, Monagle P (2007) Age-related reference ranges for TAFI and fibrin monomers in healthy children. J Throm Haemost 5(Suppl 2):P-S-397
22.
go back to reference Teufelsbauer H, Proidl S, Havel M, Vukovich T (1992) Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 68:250–252PubMed Teufelsbauer H, Proidl S, Havel M, Vukovich T (1992) Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 68:250–252PubMed
23.
go back to reference Valen G, Eriksson E, Risberg B, Vaage J (1994) Fibrinolysis during cardiac surgery: release of tissue plasminogen activator in arterial and coronary sinus blood. Eur J Cardiothorac Surg 8:324–330PubMedCrossRef Valen G, Eriksson E, Risberg B, Vaage J (1994) Fibrinolysis during cardiac surgery: release of tissue plasminogen activator in arterial and coronary sinus blood. Eur J Cardiothorac Surg 8:324–330PubMedCrossRef
24.
go back to reference Williams GD, Bratton SL, Ramamoorthy C (1999) Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open heart surgery. Anesth Analg 89:57–64PubMed Williams GD, Bratton SL, Ramamoorthy C (1999) Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open heart surgery. Anesth Analg 89:57–64PubMed
Metadata
Title
Plasmin Generation and Fibrinolysis in Pediatric Patients Undergoing Cardiopulmonary Bypass Surgery
Authors
Vera Ignjatovic
Aparajith Chandramouli
Jenny Than
Robyn Summerhayes
Fiona Newall
Steve Horton
Andrew Cochrane
Paul Monagle
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 2/2012
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-011-0122-6

Other articles of this Issue 2/2012

Pediatric Cardiology 2/2012 Go to the issue